The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Ozempic (semaglutide) is a prescription medication approved by the Food and Drug Administration (FDA) for adults with type 2 diabetes. It helps lower blood sugar levels, slow digestion, and ...

CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

While effective, Ozempic's health risks, regulatory challenges, and cultural impact are under scrutiny ... medication for weight loss, its high cost and limited availability have kept Ozempic ...

Ozempic is a prescription drug developed to manage blood sugar levels in patients with Type 2 diabetes. But it can also cause weight loss as a side effect due to its impact on appetite.

Now, drinkers are motioning for a cocktail reformation — specifically, smaller aperitifs suitable for shrinking stomachs and the health ... desires.” “Ozempic is having an impact for sure ...

Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory ...